ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
ATyr slashes headcount, cuts costs after ORCA runs aground
fiercebiotech
May 16, 2018ATyr Pharma is laying off 30% of its staff and otherwise cutting its costs in response to lackluster data. The biotech made the cuts after preclinical data on its anticancer antibodies suggested they lack the required efficacy.
Pharma Sources Insight January 2025
